X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Sarah Spurgeon

Sarah Spurgeon Sarah A. Spurgeon is Assistant General Counsel of the Pharmaceutical Research and Manufacturers of America (PhRMA) and serves as one of the principle food and drug law regulatory attorneys for the association. Ms. Spurgeon provides advice and advocacy on FDA regulatory and policy matters as well as legal counsel on federal legislation. Ms. Spurgeon’s substantive areas of expertise include the regulation of communicating information related to prescription medicines (e.g., REMS, PhRMA Code compliance, and FDAMA 114) and matters related the safety, security and quality of the global pharmaceutical supply chain (e.g., implementation of Title VII of Food and Drug Administration Safety and Innovation Act (FDASIA) and the Drug Quality and Security Act (DQSA)). Prior to her role at PhRMA, she worked in a Washington, D.C. law firm’s internationally renowned Food and Drug Law practice group. Ms. Spurgeon received her B.A., cum laude, in American Studies and Economics from Wellesley College and her J.D., cum laude, from Harvard Law School.

Recent Posts

Transparency and confidentiality in FDA’s proposed quality metrics proposal is key

By Sarah Spurgeon  |    March 15, 2016
In our last post on this topic, we discussed PhRMA member companies’ commitment to quality and introduced you to the U.S. Food and Drug Administration’s (FDA) proposed mandatory quality metrics...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates